Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review-Reference-Cited by-同舟云学术

Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review

Published:2019-12-02 Issue:12 Volume:14 Page:e0225643
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tan Qing-Qing^ORCID,Christiansen Stephen P.,Wang Jingyun^ORCID

Funder

National Eye Institute

Pennsylvania Lions Sight Conservation and Eye Research Foundation Grant

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome;BP Connolly;Ophthalmology,2002

2. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age;GE Quinn;Ophthalmology,2008

3. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group;GE Quinn;Ophthalmology,1998

4. Long-term evaluation of refractive status and optical components in eyes of children born prematurely;TC Chen;Invest Ophthalmol Vis Sci,2010

5. Development of refractive error in individual children with regressed retinopathy of prematurity;J Wang;Invest Ophthalmol Vis Sci,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating VEGF-A Levels in Relation to Retinopathy of Prematurity and Treatment Effects: A Systematic Review and Meta-Analysis;Ophthalmology Science;2024-11

2. Myopia dominance in preterm infants without and with retinopathy of prematurity: Indian Twin Cities ROP study (ITCROPS) report number 15;Acta Ophthalmologica;2024-08-16

3. Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity;JAMA Network Open;2024-04-30

4. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03

5. Five-year visual outcome of treatment for retinopathy of prematurity in infants weighing less than 500 g at birth: A multicenter cohort study from J-CREST;Retina;2023-12-06